Axel Hoos
Presidente presso Cancer Research Institute
Posizioni attive di Axel Hoos
Società | Posizione | Inizio | Fine |
---|---|---|---|
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Direttore/Membro del Consiglio | - | - |
Presidente | 11/12/2014 | - | |
Cancer Research Institute
Cancer Research Institute Medical/Nursing ServicesHealth Services Cancer Research Institute provides cancer immunotherapy services. The private company is based in New York, NY and has subsidiaries in the United States. The company was founded in 1953. Jill O'Donnell-Tormey has been the CEO of the company since 1987. | Presidente | - | - |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Direttore/Membro del Consiglio | 21/03/2023 | - |
Storia della carriera di Axel Hoos
Precedenti posizioni note di Axel Hoos
Società | Posizione | Inizio | Fine |
---|---|---|---|
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Direttore/Membro del Consiglio | 31/08/2021 | 04/01/2024 |
Amministratore Delegato | 31/08/2021 | 04/01/2024 | |
TCR2 THERAPEUTICS INC. | Direttore/Membro del Consiglio | 13/04/2020 | 01/06/2023 |
Independent Dir/Board Member | 13/04/2020 | 01/06/2023 | |
IMUGENE LIMITED | Direttore/Membro del Consiglio | 20/10/2013 | 19/11/2021 |
Fondatore | 20/10/2013 | 19/11/2021 | |
Independent Dir/Board Member | 20/10/2013 | 19/11/2021 | |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2005 | 01/01/2011 |
AGENUS INC. | Corporate Officer/Principal | 01/01/2001 | 01/01/2005 |
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01/01/2012 | - |
Formazione di Axel Hoos
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Australia | 2 |
Germania | 2 |
Posizioni
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Chairman | 2 |
Settori
Health Technology | 7 |
Commercial Services | 3 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
AGENUS INC. | Health Technology |
IMUGENE LIMITED | Health Technology |
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Health Technology |
Aziende private | 5 |
---|---|
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Commercial Services |
Cancer Research Institute
Cancer Research Institute Medical/Nursing ServicesHealth Services Cancer Research Institute provides cancer immunotherapy services. The private company is based in New York, NY and has subsidiaries in the United States. The company was founded in 1953. Jill O'Donnell-Tormey has been the CEO of the company since 1987. | Health Services |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Health Technology |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Commercial Services |
- Borsa valori
- Insiders
- Axel Hoos
- Esperienza